These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 12920954)

  • 1. [Clinical manifestations of APS-nephropathy in primary antiphospholipid syndrome].
    Shilov EM; Kozlovskaia NL; Meteleva NA; Kozlovskaia LV; Varshavskiĭ VA; Miroshnichenko NG; Blokhina GV; Serova AG; Nesterova SG; Smolianitskiĭ AIa
    Ter Arkh; 2003; 75(6):22-7. PubMed ID: 12920954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicomorphological features of nephropathy in primary and secondary antiphospholipid syndrome].
    Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Kushnir VV; Shakhnova EA; Miroshnichenko NG; Serova AG; Nesterova SG
    Ter Arkh; 2007; 79(6):16-25. PubMed ID: 17684961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
    Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P
    Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kidney damage in primary antiphospholipid syndrome].
    Kozlovskaia NL; Tareeva IE; Kamyshova ES; Varshavskiĭ VA; Miroshnichenko NG; Kotliarova GV
    Ter Arkh; 2001; 73(6):25-31. PubMed ID: 11521516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-phospholipid syndrome nephropathy].
    Nochy D; Daugas E; Hill G; Piette JC
    Ann Med Interne (Paris); 2003 Feb; 154(1):51-8. PubMed ID: 12746659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies and renal involvement.
    Gigante A; Gasperini ML; Cianci R; Barbano B; Giannakakis K; Di Donato D; Fuiano G; Amoroso A
    Am J Nephrol; 2009; 30(5):405-12. PubMed ID: 19713697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS.
    Tektonidou MG; Sotsiou F; Moutsopoulos HM
    J Rheumatol; 2008 Oct; 35(10):1983-8. PubMed ID: 18688914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of antiphospholipid syndrome nephropathy (APSN) in patients with systemic lupus erythematosus (SLE).
    Miranda JM; Jara LJ; Calleja C; Saavedra MA; Bustamante RM; Angeles U
    Reumatol Clin; 2009; 5(5):209-13. PubMed ID: 21794612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus.
    Daugas E; Nochy D; Huong DLT; Duhaut P; Beaufils H; Caudwell V; Bariety J; Piette JC; Hill G
    J Am Soc Nephrol; 2002 Jan; 13(1):42-52. PubMed ID: 11752020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal involvement in primary antiphospholipid syndrome.
    Amigo MC; Garcia-Torres R; Robles M; Bochicchio T; Reyes PA
    J Rheumatol; 1992 Aug; 19(8):1181-5. PubMed ID: 1404151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiphospholipid syndrome and the kidney diseases].
    Majdan M
    Pol Merkur Lekarski; 2010 May; 28(167):341-4. PubMed ID: 20568393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney disease in antiphospholipid syndrome.
    Amigo MC
    Rheum Dis Clin North Am; 2006 Aug; 32(3):509-22. PubMed ID: 16880081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid syndrome and the kidneys.
    Uthman I; Khamashta M
    Semin Arthritis Rheum; 2006 Jun; 35(6):360-7. PubMed ID: 16765713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
    Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
    Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nephropathy in patients with primary antiphospholipid antibody syndrome].
    Yoshida A; Morozumi K; Takeda A; Koyama K; Ideura T; Oikawa T
    Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):158-62. PubMed ID: 8139148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal involvement in primary antiphospholipid syndrome.
    Marcantoni C; Emmanuele C; Scolari F
    J Nephrol; 2016 Aug; 29(4):507-15. PubMed ID: 27198137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two cases of systemic lupus erythematosus accompanied by antiphospholipid syndrome nephropathy without immune complex nephritis].
    Komiya T; Okamura M; Kawakami K; Okazaki M; Tsukamoto J; Okada S; Sumi T; Negoro N; Yoshikawa J
    Nihon Jinzo Gakkai Shi; 2002 Dec; 44(8):817-22. PubMed ID: 12607972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment.
    Tektonidou MG
    Front Immunol; 2018; 9():1181. PubMed ID: 29904380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.